TLR4 and serum lipopolysaccharide activity: These findings reveal that SB prevents myocardial injury caused by ISO through strengthening gut barrier protection, alleviating endotoxemia, inhibiting TLR4/NF-κB, and remodeling the microbiome-metabolome axis, indicating its potential for use as a gut-targeted cardioprotective intervention.